No other clinicopathologic or demographic variable, including sex, BMI group, tumor location, TNM stage, chronic disease status, or family history of cancer, showed a significant relationship with the expression of RUSC1-AS1, SNHG17, PABPC1L, or SNHG1 (all p > 0.05). This evidence concerns the gene SNHG17 and cancer.